Slegers J F, Förster M T, Moons W M
Arch Int Pharmacodyn Ther. 1981 Mar;250(1):147-63.
Isolated kidneys of normotensive Wistar rats (NWR) and of genetically hypertensive Kyoto rats (SHR) were perfused. Contraction of intrarenal vascular smooth muscle cells were induced by barium ions (0.1 to 1.0 mmol) as well as by high potassium concentrations (40 mmol). It was shown that barium stimulates intracellular calcium stores to release activator calcium. Repeated stimulation with barium under calcium-free perfusion conditions resulted in depletion of these stores. In kidneys of SHR rats the tension development in response to barium was stronger as compared with NWR rats and the time needed to deplete the stores was prolonged. This suggests that smooth muscle cells of SHR rats contain more sequestered calcium. Diazoxide inhibited the barium contracture rapidly, reversibly and dose dependently. The inhibition was non-competitive. Percentual inhibition was equal in NWR and in SHR rat kidneys. Moreover, diazoxide did not block the calcium influx across the sarcolemma membrane. The magnitude of the potassium contractures depended entirely upon the extracellular calcium concentration. In the range of 0.1 to 1.0 mmol calcium, tension development varied linearly with log calcium concentration. Diazoxide also inhibited the potassium contractures, provided normally filled calcium stores were available. The combined results strongly suggest that diazoxide prevents intracellular calcium stores to release calcium and, furthermore, that this action is the basic mechanism of the vasodilating activity of diazoxide in smooth muscle cells of rat intrarenal vessels.
对正常血压的Wistar大鼠(NWR)和遗传性高血压的京都大鼠(SHR)的离体肾脏进行灌注。用钡离子(0.1至1.0 mmol)以及高钾浓度(40 mmol)诱导肾内血管平滑肌细胞收缩。结果表明,钡刺激细胞内钙库释放激活钙。在无钙灌注条件下用钡反复刺激会导致这些钙库耗尽。与NWR大鼠相比,SHR大鼠肾脏对钡的张力发展更强,且耗尽钙库所需的时间延长。这表明SHR大鼠的平滑肌细胞含有更多的储存钙。二氮嗪能快速、可逆且剂量依赖性地抑制钡挛缩。这种抑制是非竞争性的。NWR和SHR大鼠肾脏的抑制百分比相同。此外,二氮嗪不会阻断钙通过肌膜的内流。钾挛缩的幅度完全取决于细胞外钙浓度。在0.1至1.0 mmol钙的范围内,张力发展与对数钙浓度呈线性变化。如果有正常充盈的钙库,二氮嗪也会抑制钾挛缩。综合结果强烈表明,二氮嗪可阻止细胞内钙库释放钙,此外,这一作用是二氮嗪在大鼠肾内血管平滑肌细胞中舒张血管活性的基本机制。